Erik J Uhlmann
Overview
Explore the profile of Erik J Uhlmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baboli M, Wang F, Dong Z, Dietrich J, Uhlmann E, Batchelor T, et al.
Radiology
. 2024 Sep;
312(3):e232401.
PMID: 39315894
Background: MR spectroscopic imaging (MRSI) can be used to quantify an extended brain metabolic profile but is confounded by changes in tissue water levels due to disease. Purpose: To develop...
2.
White B, Filo J, Orrego-Gonzalez E, Schwartz S, Varma H, Uhlmann E, et al.
J Neuropathol Exp Neurol
. 2023 Oct;
82(12):1048-1050.
PMID: 37875098
No abstract available.
3.
Wong E, Rosenberg H, Dawood O, Hertan L, Vega R, Anderson M, et al.
BMC Neurol
. 2023 Jul;
23(1):257.
PMID: 37403078
Background: Elderly patients with glioblastoma are particularly susceptible to the adverse effects of ionizing radiation to the brain. This population also has an increasing prevalence of dementia in the successive...
4.
Mackel C, Rosenberg H, Varma H, Uhlmann E, Vega R, Alterman R
Brain Tumor Res Treat
. 2023 May;
11(2):103-113.
PMID: 37151152
Background: Cerebral chondrosarcoma metastases are rare and aggressive neoplasms. The rarity of presentation has precluded rigorous analysis of diagnosis, risk factors, treatment, and survival. We analyzed every reported case through...
5.
Uhlmann E, Mackel C, Deforzh E, Rabinovsky R, Brastianos P, Varma H, et al.
J Neurooncol
. 2023 Feb;
162(1):109-118.
PMID: 36809604
Purpose: Meningioma is the most common primary central nervous system tumor often causing serious complications, and presently no medical treatment is available. The goal of this study was to discover...
6.
Zhang Y, Rabinovsky R, Wei Z, El Fatimy R, Deforzh E, Luan B, et al.
Mol Ther Nucleic Acids
. 2023 Jan;
31:265-275.
PMID: 36700043
MicroRNA-10b (miR-10b) is an essential glioma driver and one of the top candidates for targeted therapies for glioblastoma and other cancers. This unique miRNA controls glioma cell cycle and viability...
7.
Uhlmann E, Rabinovsky R, Varma H, El Fatimy R, Kasper E, Moore J, et al.
J Neuropathol Exp Neurol
. 2022 Jun;
81(12):1041.
PMID: 35735214
No abstract available.
8.
Yeo A, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, et al.
Nat Immunol
. 2022 May;
23(6):971-984.
PMID: 35624211
Glioblastoma (GBM) is an incurable primary malignant brain cancer hallmarked with a substantial protumorigenic immune component. Knowledge of the GBM immune microenvironment during tumor evolution and standard of care treatments...
9.
Deforzh E, Uhlmann E, Das E, Galitsyna A, Arora R, Saravanan H, et al.
Mol Cell
. 2022 Apr;
82(10):1894-1908.e5.
PMID: 35390275
miR-10b is silenced in normal neuroglial cells of the brain but commonly activated in glioma, where it assumes an essential tumor-promoting role. We demonstrate that the entire miR-10b-hosting HOXD locus...
10.
Miller E, Patell R, Uhlmann E, Ren S, Southard H, Elavalakanar P, et al.
Blood Adv
. 2022 Jan;
6(5):1559-1565.
PMID: 35086145
Although intracranial hemorrhage (ICH) is frequent in the setting of brain metastases, there are limited data on the influence of antiplatelet agents on the development of brain tumor-associated ICH. To...